Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
&NA; Inflammation is a major contributor to the secondary damage that occurs after spinal cord injury (SCI). The inflammatory response is coordinated by many different signaling modalities including the epigenetic modification of promoters and enhancers. Bromodomain and extraterminal domain‐containing proteins (BETs; Brd2, Brd3, Brd4, BrdT) are epigenetic readers that bind acetylated histones to promote transcription of pro‐inflammatory genes. BET inhibition is anti‐inflammatory in animal models of cancer, rheumatoid arthritis, and coronary artery disease. However, the role of BETs in neuroinflammation remains largely unexplored. In this study, we investigated the role of BETs in promoting inflammation in neural cells and the ability of the BET inhibitor JQ1 to decrease inflammation acutely after SCI. Expression of BET mRNA was assessed via qPCR in purified primary mouse macrophages, astrocytes, neurons, oligodendrocytes, and microglia, as well as in naïve, sham‐injured, and contusion‐injured mouse spinal cord. Brd2, Brd3, and Brd4 mRNA were expressed in all purified primary neural cells and in the uninjured and injured mouse spinal cord. BET inhibition significantly attenuated proinflammatory signaling in all activated cell populations in vitro. To investigate the effects of BET modulation after SCI, the BET inhibitor JQ1 was injected intraperitoneally (30 mg/kg, bidaily) 3 h after spinal cord contusion in adult female C57BL/6 mice. By 3 days post‐injury, BET inhibition significantly decreased pro‐inflammatory cytokine expression and leukocyte recruitment to the injury site. However, this decrease did not lead to locomotor improvements or smaller lesion size. Taken together, our data implicate BETs as regulators of multiple key pro‐inflammatory cytokines, and suggest that BETs can be pharmacologically inhibited to reduce inflammation acutely after SCI. HighlightsBETs are epigenetic readers expressed in all CNS cell‐types in vitro.BET inhibition attenuates cytokine expression by all CNS cell types in vitro.BET inhibition reduces expression of multiple pro‐inflammatory cytokines after SCI.BET inhibition reduces leukocyte infiltration acutely after SCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563 · cited 10×
“Due to the unique loop-regions flanking the bromodomains of BETs, these small-molecule inhibitors are highly selective for BET bromodomains over other bromodomain-containing proteins, thus limiting their off-target effects (Filippakopoulos et al., 2010; Nicodeme et al., 2010).”
InfluentialT cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 3×
“JQ1 treatment also increased the pro-inflammatory cytokines Il-17a and Il-23a (Fossiez et al., 1996; Oppmann et al., 2000), the proliferation-inducing cytokine Il-11 (Harmegnies et al.”
Zhu, Y., Soderblom, C., Krishnan, V., Ashbaugh, J., Bethea, J. R., & Lee, J. K. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.024 · Cited by 199
Self-citationJahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K. G., Hansen, H. C., Wagner, G. S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.008 · Cited by 134
Xing, B., Bachstetter, A. D., & Van Eldik, L. J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-84 · Cited by 101 · cited 1×
“Cytokines promote apoptosis of local neuronal cells as well as recruitment of activated leukocytes into the injured spinal cord (Beck et al., 2010; Chen et al., 2011; D'Souza et al., 1995; Saiwai et al., 2010; Stirling and Yong, 2008; Xing et al., 2011).”
DeMars, K. M., Yang, C., Castro-Rivera, C. I., & Candelario-Jalil, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.096 · Cited by 66 · cited 2×
“In purified primary astrocytes and microglial cell lines, BET inhibition attenuates cytokine synthesis (Choi et al., 2015; Demars et al., 2018; Jung et al., 2015).”
Cited by
The BET family in immunity and disease
Wang, N., Wu, R., Tang, D., & Kang, R. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00384-4 · Cited by 295
Ghiboub, M., Elfiky, A. M. I., de Winther, M. P. J., Harker, N. R., Tough, D. F., & de Jonge, W. J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050336 · Cited by 28
Epigenetic modifications of inflammation in spinal cord injury
Lu, Z.-J., Pan, Q.-L., & Lin, F.-X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117306 · Cited by 14
Metadata
- Authors
- Rudman, M. D., Choi, J. S., Lee, H. E., Tan, S. K., Ayad, N. G., & Lee, J. K.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 309
- Pages
- 181-192
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2886230073
- Cited by
- 41
- References
- 7
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. https://app.cochat.ai/papers/10.1016/j.expneurol.2018.08.005
- The paper
- Rudman, M. D., Choi, J. S., Lee, H. E., Tan, S. K., Ayad, N. G., & Lee, J. K. (2018). Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2018.08.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.